FDA inspection
Daiichi Sankyo Co., Ltd.: FDA inspection ending Dec 22, 2023
FDA inspection 1226353 · Voluntary Action Indicated (VAI) · Iwaki
Key facts
| Inspection ID | 1226353 |
|---|---|
| Firm | Daiichi Sankyo Co., Ltd. |
| FEI number | 3002808054 |
| Address | 389-4, Izumimachi Shimokawa Aza Otsurugi, Izumimachishimogawa |
| City | Iwaki |
| Country | Japan |
| Fiscal year | 2024 |
| Inspection end date | Dec 22, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data